Загрузка...
Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro
BACKGROUND: Rasagiline, a new drug developed to treat Parkinson's disease, is known to inhibit monoamine oxidase B. However, its metabolite R-(-)-aminoindan does not show this kind of activity. The present series of in vitro experiments using the rat hippocampal slice preparation deals with eff...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3051903/ https://ncbi.nlm.nih.gov/pubmed/21338509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2210-11-2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|